Navigation Links
US FDA Official Rick Friedman to Present Plenary at ISPE Aseptic Education Intensive
Date:2/21/2013

Tampa, Fla. USA (PRWEB) February 21, 2013

ISPE announced today that Rick Friedman, Associate Director, OMPQ, US FDA, will be the plenary speaker at the association’s two-day education intensive on aseptic processes for the pharmaceutical industry. The event will take place on 4 – 5 March 2013 in Baltimore, Maryland USA.

“ISPE conferences are an important neutral meeting-ground for regulators and pharmaceutical professionals from around the world to discuss technical challenges,” said Nancy Berg, ISPE President and CEO. “By bringing together top industry experts and high-level regulators like Mr. Friedman, ISPE will facilitate collaboration and sharing of best practices that is essential to the production of a safe global drug supply.”

The two-day event will present the latest in aseptic processes. Discussions will focus on disposables, barrier isolation and containment technologies, cleaning and sterilization. Regulators and pharma experts will present state-of-the-art developments in sterile process improvements, risk mitigation, cost-effective processing and innovative applications.

In addition to Friedman, notable speakers at this conference include:

  • Charlotte Enghave Fruergaard, PhD, Director of Technology, NNE Pharmaplan, 2012-2013 Chair, ISPE International Board of Directors, Aseptic Conference Honorary Chair
  • Destry Sillivan, Senior Regulatory Review Officer, US FDA
  • Robert Sausville, Director, Division of Case Management (DCM) Office of Compliance and Biologics Quality, at FDA’s Center for Biologics Evaluation and Research, US FDA
  • Dave Doleski, Acting Director, Division of Good Manufacturing Practice Assessment, OMPQ, OC, CDER, US FDA

Pharma industry executives leading this event and serving as moderators include:

  • Ryan Hawkins, Vice President Operations, Cook Pharmica, USA
  • Jack Lysfjord, Principal Consultant, Lysfjord Consulting LLC, USA
  • Joerg Zimmermann, Director Process Development and Implementation, Vetter Pharma Fertigung GmbH & Co. KG, Germany
  • Rebecca Brewer, Director, Validation and GMP Compliance, Dober Group, USA
  • Gordon Leichter, PhD, Regional Sales Manager, Belimed, Inc., USA

More information on the 2013 ISPE Aseptic Intensive, including complete education details and registration information, is available at http://www.ISPE.org/2013AsepticConference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit http://www.ISPE.org for more information.

Read the full story at http://www.prweb.com/releases/ISPE/2013AsepticConference/prweb10455025.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tianli-Xiduhei(TM) Black Pork Meat Makes Official Debut in Beijing Food Stores
2. How to Check for Bed Bugs in Houses, Hotels and Offices - CheckForBedBugs.com Releases It's Official Easy-to-Follow Guide
3. Officials Find Bed Bugs in Wall Street Journal; Spray For Bed Bugs Offers Advice How to Safely Counter Possible Bed Bug Comeback
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. The BBVA Foundation Frontiers of Knowledge Award goes to Coleman and Friedman, discoverers of the appetite hormone
6. Life Technologies to Present at Barclays Global Healthcare Conference
7. AbbVie to Present at Cowen and Company 33rd Annual Health Care Conference
8. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
9. PDL BioPharma to Present at Two Upcoming Investor Conferences
10. Sigma-Aldrich Corporation Declares Increased Quarterly Dividend; Announces Live Webcasts Of Presentations At Two Upcoming Conferences
11. Patheon to Present at Informex USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, Inc. ... "Company"), announced that on January 14, 2017 the Board ... which the Company will terminate certain employees associated with ... Inc.  The Company commenced terminations on January 16, 2017 ... days.  The Company may pay severance benefits in certain ...
(Date:1/20/2017)... -- Ginkgo Bioworks, the organism company, announced today ... synthesis and assembly of DNA. The acquisition will ... DNA into Ginkgo,s automated organism engineering foundries, enabling ... new organism designs for application across a wide ... to significantly increase the world,s capacity to cost-effectively ...
(Date:1/19/2017)... LOUISVILLE, Ky. and HOUSTON ... Prenatal Inc. ("NX Prenatal") today announced the formation ... brings together leading clinicians and industry veterans who ... the company as it accelerates development of its ... positioned to provide medical, clinical and strategic guidance ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
Breaking Biology Technology:
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a ... with the release of its patent-pending calibration device. With ... reliably perform calibrations, securely upload data logs and process ... the customer. "Fighting drunk driving through the ... the public at large, but also for the customer ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CES® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
Breaking Biology News(10 mins):